NCT04500184

Brief Summary

Thoracoscopic ablation is a promising treatment of persistent atrial fibrillation. However, the postoperative rehabilitation is very important to prevent early recurrence of atrial arrhythmia. The purpose of this study is to evaluate the efficacy of professional cardiac rehabilitation in patients after thoracoscopic ablation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2018

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 5, 2020

Completed
Last Updated

August 5, 2020

Status Verified

July 1, 2020

Enrollment Period

12 months

First QC Date

July 24, 2020

Last Update Submit

July 31, 2020

Conditions

Atrial Fibrillation, PersistentCardiac RehabilitationCardiopulmonary Fitness

Outcome Measures

Primary Outcomes (2)

  • Recurrence of atrial fibrillation

    Atrial fibrillation recurrence after surgical treatment

    every 6 months for 1 year

  • functional recovery

    exercise capacity and international physical activity questionnaire

    6 months after intervention

Study Arms (2)

Exercise group

patients who underwent cardiac rehabilitation

Other: cardiac rehabilitation

Control group

patients who did not undergo cardiac rehabilitation

Interventions

cardiac rehabilitationOTHER

rehabilitation performed by professional trainers

Exercise group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent thoracoscopic ablation were included. cardiac rehabilitation was performed according to the willingness of each patients.

You may qualify if:

  • patients who underwent thoracoscopic ablation due to persisent atrial fibrillation

You may not qualify if:

  • below 18 years
  • over 80 years old
  • malignancy
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, 135-710, South Korea

Location

MeSH Terms

Conditions

Atrial Fibrillation

Interventions

Cardiac Rehabilitation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Dong Seop Jeong, PhD

    Samsung Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

July 24, 2020

First Posted

August 5, 2020

Study Start

June 1, 2017

Primary Completion

May 30, 2018

Study Completion

May 31, 2020

Last Updated

August 5, 2020

Record last verified: 2020-07

Locations

KR(1)